High Cholesterol

High LDL cholesterol is a primary driver of atherosclerosis, the arterial plaque buildup that underlies heart attacks and strokes worldwide. LDL particles that enter and stay in the artery wall drive plaque, and inflammation, oxidation and insulin resistance add to the damage over decades. A targeted dietary approach can meaningfully lower LDL and support vascular health. In the best-studied pattern of this kind, the Portfolio diet, LDL fell by about 17% across 7 controlled trials, and by 35% in one small 4-⁠week trial2.

Cardiovascular & Metabolic Evidence-Based

Last updated:

โš ๏ธ Medication safety: please read first. The nutrition and supplement approaches on this page are meant to work alongside your prescribed treatment, never to replace it. Never stop, reduce or change your cholesterol-lowering medication without your prescriber's guidance. Doing so can be dangerous. Several supplements interact with cholesterol-lowering medication, so talk to your prescriber or pharmacist before starting anything on this page.

What Is High Cholesterol?

Hypercholesterolemia is defined as total blood cholesterol above 200 mg/dL, with LDL cholesterol above 130 mg/dL considered borderline-high. LDL particle number matters most, and inflammation and oxidation of LDL in the artery wall are part of how plaque forms.

Cholesterol is a vital molecule: it forms every cell membrane in the body, is the backbone of all steroid hormones (cortisol, estrogen, testosterone, vitamin D), enables bile production for fat digestion, and is essential for brain function. Recent guidelines dropped a specific daily limit for cholesterol in food: observational studies show no consistent link with heart disease, though intakes above today's average raise LDL in most trial analyses23.

Atherosclerosis, the progressive hardening and narrowing of arteries from plaque deposits, is the underlying mechanism behind coronary artery disease, heart attacks and ischemic strokes. The good news: LDL lowering through diet and, where needed, medication reduces cardiovascular events.

โš ๏ธ Important: High cholesterol is a cardiovascular risk factor that requires clinical assessment. If you have been diagnosed with familial hypercholesterolemia, or have existing cardiovascular disease, please work with your physician before modifying or stopping statin therapy. The nutritional strategies here are evidence-based and many can be used alongside conventional treatment.
An artery cut open to show yellow cholesterol plaque narrowing it, a close-up of cholesterol among blood cells and a blood drop labeled high cholesterol, beside an oil bottle, avocado, garlic and leaves labeled healthy diet

Understanding Your Cholesterol Numbers

Total CholesterolDesirable: <200 mg/dL
LDL ("Bad")Optimal: <100 mg/dL (high-risk: <70)
HDL ("Good")Optimal: >60 mg/dL
TriglyceridesNormal: <150 mg/dL
ApoB (best marker)Optimal: <70 mg/dL
hs-CRP (inflammation)Optimal: <1 mg/L

Types & Classifications

๐Ÿงฌ Primary / Familial Hypercholesterolemia

Genetically driven: mutations in the LDL receptor gene (LDLR), ApoB gene or PCSK9 gene impair LDL clearance from the blood. Familial Hypercholesterolemia (FH) affects 1 in 250 people and causes LDL levels above 190 mg/dL despite a healthy diet. Heterozygous FH raises cardiovascular risk 3 to 10x; homozygous FH (1 in 300,000) requires aggressive intervention. Statin therapy is typically essential; diet supports it.

โš–๏ธ Secondary Hypercholesterolemia

Cholesterol elevation caused by an underlying, addressable condition: hypothyroidism (substantially raises LDL; always test TSH in hypercholesterolemia), type 2 diabetes / insulin resistance (raises triglycerides and small dense LDL), chronic kidney disease, liver disease, obstructive sleep apnea and medications (thiazide diuretics, beta blockers, corticosteroids, anabolic steroids, retinoids). Secondary causes must be ruled out before initiating statin therapy.

๐Ÿ”€ Mixed Dyslipidemia

The most metabolically dangerous pattern, elevated LDL combined with high triglycerides (>150 mg/dL) and low HDL (<40 mg/dL in men, <50 mg/dL in women). This "atherogenic triad" is the lipid signature of insulin resistance, metabolic syndrome and NAFLD (nonalcoholic fatty liver disease). Even with a "normal" LDL number, high triglycerides and low HDL indicate significant cardiovascular risk. The dietary change most consistently associated with improving this pattern is reducing refined carbohydrates and sugar.

High Cholesterol by the Numbers

86M
US adults with total cholesterol above 200 mg/dL (CDC)1
17%
LDL reduction from the Portfolio dietary pattern, pooled across 7 controlled trials2
6 to 12%
LDL reduction from plant sterols at 0.6 to 3.3 g/day, across 124 placebo-controlled trials6
25%
cardiovascular event reduction with prescription-dose EPA, in statin-treated patients with high triglycerides (REDUCE-IT)5
25M
US adults with total cholesterol above 240 mg/dL, the high range (CDC)19
~1 in 5
fewer major vascular events each year for every 39 mg/dL (1 mmol/L) fall in LDL, across 26 trials in about 170,000 people16

Symptoms of High Cholesterol

High cholesterol is almost entirely asymptomatic until vascular damage is advanced, hence the term "silent killer." By the time symptoms appear, atherosclerosis has typically been progressing for 20 to 30 years.

SymptomWhat happens
Early & Subtle Signs
Xanthelasma & Corneal ArcusYellowish fatty deposits under the eyelid skin (xanthelasma) or a gray-white arc around the cornea (corneal arcus before age 45) are direct cholesterol deposits, visible markers of hypercholesterolemia or familial hypercholesterolemia. Tendon xanthomas (fatty bumps over the Achilles tendon or knuckles) indicate severe, long-standing cholesterol elevation and strongly suggest FH.
Peripheral Artery Disease SymptomsAtherosclerosis affecting the leg arteries causes claudication: cramping, aching or fatigue in the calves, thighs or buttocks during walking that resolves with rest. As disease progresses: cold feet, diminished foot pulses, non-healing wounds on the toes or feet, and skin color changes. PAD is a major marker of systemic atherosclerosis; its presence correlates strongly with coronary and carotid artery disease.
Erectile Dysfunction as Early WarningEndothelial dysfunction, the impaired ability of blood vessel walls to relax and dilate, is one of the earliest manifestations of atherosclerosis. The penile arteries are smaller than the coronary arteries, and ED often precedes cardiac symptoms by 3 to 5 years in men with underlying cardiovascular disease. ED in men under 50 is now considered a cardiovascular risk marker.
Advanced & Emergency Signs
Chest Pain (Angina)Stable angina (chest tightness, pressure or pain triggered by exertion and relieved by rest or nitrates) indicates significant coronary artery narrowing (>70% occlusion). Unstable angina (occurring at rest or with increasing frequency/​severity) is a cardiovascular emergency. Atherosclerotic plaque rupture, triggered by inflammation, causes acute myocardial infarction (heart attack).
TIA & Stroke SymptomsCarotid artery atherosclerosis causes transient ischemic attacks (TIAs, "mini-strokes"): sudden one-sided weakness or numbness, speech difficulty, visual disturbance or severe headache lasting minutes to hours. TIA is a medical emergency: in a large US study, 10.5% of people seen in the emergency department with a TIA had a stroke within 90 days, half of them within 2 days35.
Elevated Triglycerides & Fatty LiverSeverely elevated triglycerides (above 500 mg/dL) raise the risk of acute pancreatitis, a potentially life-threatening emergency with severe abdominal pain, nausea and vomiting. Moderate hypertriglyceridemia (150 to 500 mg/dL) drives NAFLD, fat accumulation in the liver that can progress to NASH (nonalcoholic steatohepatitis), cirrhosis and liver cancer. The dietary change most consistently linked to lower triglycerides is cutting sugar, fructose and refined carbohydrates, and stopping alcohol entirely.

Causes of High Cholesterol

Cholesterol levels are set by inherited factors, diet, weight, activity and other conditions acting together, and risk rises with age20.

CauseHow It Contributes to High CholesterolWhat Helps
Saturated and trans fatA diet high in saturated fat and trans fat may contribute to high cholesterol and heart disease20Replacing them with olive oil, nuts, avocado, fatty fish and soluble fiber, as the diet section sets out
Inherited high cholesterol (familial hypercholesterolemia)An inherited condition causes very high LDL from a young age that, left untreated, worsens with age20Lipid-lowering medication set by a clinician, with diet as support; testing close relatives
Low activity and weight gainNot getting enough activity can lead to weight gain, which can raise cholesterol20Regular activity and the diet section's food pattern
Type 2 diabetesType 2 diabetes lowers HDL and raises LDL20Good diabetes care and cutting refined carbohydrates and added sugar, as the diet section advises
SmokingSmoking damages blood vessels so fatty deposits collect more easily, and may lower HDL20Stopping smoking, with support from a clinician
AgeThe body clears cholesterol from the blood less well with age, so risk rises for everyone20Regular lipid testing, so a rise is found early

How High Cholesterol Is Diagnosed

The standard lipid panel is the basis of risk assessment, and some further tests add information.

TestWhat it shows
Standard Lipid Testing
Fasting Lipid PanelThe basic screen: total cholesterol, LDL-C (often calculated, not directly measured), HDL-C and triglycerides. Fasting 9 to 12 hours before testing improves accuracy, especially for triglycerides. The standard panel should be obtained at least every 5 years from age 20. When you are treated for high cholesterol, it is repeated 4 to 12 weeks after starting or changing treatment, then every 3 to 12 months as needed13.
ApoB: The Superior LDL MarkerApolipoprotein B is the structural protein of every atherogenic lipoprotein particle (LDL, VLDL, IDL, Lp(a)). One ApoB = one atherogenic particle. ApoB directly measures the total number of particles that can penetrate arterial walls, and predicts risk better than LDL-C does. Target: ApoB <70 mg/dL (optimal), <60 mg/dL (very high-risk).
Lp(a): The Genetic WildcardLipoprotein(a) is more than 90% set by genes, lifestyle changes have minimal effect on it, and it is an independent cardiovascular risk factor. High Lp(a) (above 50 mg/dL or 125 nmol/L) affects an estimated 1.4 billion people worldwide and raises the risk of heart attack, stroke and aortic stenosis. A European consensus advises measuring Lp(a) at least once in adults, and does not recommend niacin to lower it, because two outcome trials found no clinical benefit24. See the niacin entry in the supplement table below before considering it.
Advanced Cardiovascular Testing
Coronary Artery Calcium (CAC) ScoreThe CAC scan (CT-based, no contrast) quantifies calcified plaque in the coronary arteries, providing a direct, personalized measure of existing atherosclerotic burden. A CAC of 0 in someone over 50 (absent familial risk factors) indicates substantially lower short-term risk, and is one input your clinician may weigh when discussing whether statin therapy is warranted. It is not on its own a reason to stop or decline treatment. A CAC above 100 indicates significant plaque and warrants aggressive intervention.
hs-CRP & Inflammatory MarkersHigh-sensitivity C-reactive protein (hs-CRP) reflects systemic inflammation, the key co-driver of cardiovascular risk alongside LDL. hs-CRP is a risk marker; it is not a treatment target in current cholesterol guidelines.

Conventional and Holistic Treatment for High Cholesterol

๐ŸŒฟ HOLISTIC
๐Ÿ’Š CONVENTIONAL
๐ŸŒฟ

Holistic / Functional Approach

Lipid-lowering diet, berberine, plant sterols, omega-⁠3, red yeast rice, psyllium, vitamin K2, nattokinase

Berberine Evidence
Small reductions in LDL and triglycerides in meta-analyses, from trials mostly in China3
Dietary Impact
Dietary patterns emphasizing soluble fiber, plant sterols, soy protein and nuts lowered LDL by about 17% across 7 controlled trials, and by 35% in one small 4-⁠week trial2
Timeline
Lipids are rechecked 4 to 12 weeks after starting or adjusting treatment.13
Advantage
Diet lowers LDL and can also improve weight, blood sugar and blood pressure

Full Holistic Approach Includes

  • An anti-atherogenic dietary pattern (see Diet section below), the foundation of cholesterol management.2
  • Plant sterols and stanols: structurally mimic cholesterol and competitively block its intestinal absorption.6
  • Omega-⁠3 fatty acids: EPA reduces VLDL synthesis and triglycerides.5
  • Psyllium husk (10 to 15 g/day in two doses with water), a soluble fiber that binds bile acids and lowered LDL by about 14 mg/dL in pooled trials10
  • Red yeast rice: discuss with your doctor before taking any. Its active compound, monacolin K, is chemically identical to a prescription statin, so this is a statin whether or not it is sold as a supplement. European regulators cap supplements at under 3 mg of total monacolins per day; EFSA judged intakes of 10 mg/day a significant safety concern and recorded severe reactions, including rhabdomyolysis and liver injury, at intakes as low as 3 mg/day. The FDA treats monacolin K as an unapproved drug. Product quality also varies: in one analysis of 35 red yeast rice supplements, 16 contained detectable citrinin, a toxin that can harm the kidneys, though all were within the European limit. Never combine it with a prescription statin, and do not use it as a statin substitute without medical supervision4
  • Nattokinase (2,000 to 4,000 FU/day), an enzyme from fermented soy with trial evidence for lower fibrinogen (a cardiovascular risk factor) and clotting factors; no reliable evidence of plaque reduction. Not suitable with anticoagulant or antiplatelet medications; because of its bleeding risk, do not start it without medical advice (see the supplement table)
  • CoQ10 (200 to 400 mg ubiquinol/day), sometimes suggested with red yeast rice or statins, which lower circulating CoQ10; trial evidence for benefit is mixed
โœ… Key point: These are complements to lipid-lowering medication where it is indicated, not substitutes for it, and the choice belongs with your prescriber.

Evidence-Based Supplements for High Cholesterol

These supplements can support diet and, where indicated, medication.

SupplementWhat it is forTypical rangeTimingNotes & cautions
Berberine HClHelps the liver clear LDL from the blood. Meta-analyses of randomized trials report reductions in LDL of about 18 mg/dL (0.46 mmol/L) and triglycerides of about 30 mg/dL (0.34 mmol/L), which reviewers call small.3Set with your prescriberWith mealsIf your prescriber agrees, start at 500 mg once daily for 1 week, then increase to twice daily, then 3 times daily, to limit loose stools and nausea. Berberine inhibits CYP3A4 and P-glycoprotein, so it can raise blood levels of many prescription medicines, and it lowers blood sugar on its own. Check with your prescriber before starting it, particularly alongside glucose-lowering medication, an anticoagulant, an immunosuppressant or any drug with a narrow safe range. Not for use in pregnancy or breastfeeding.
Plant Sterols / StanolsSimilar in structure to cholesterol, they block its absorption in the gut. A meta-analysis of 124 placebo-controlled trials in 9,600 adults found a dose-response reduction in LDL of 6 to 12% across intakes of 0.6 to 3.3 g/day, around 10% at 2 g/day, without affecting HDL or triglycerides.6Set with your prescriberWith meals containing some fatDo not exceed 3 g/day (may reduce fat-soluble vitamin absorption). Carotene and vitamin E levels may decrease slightly; compensate with colorful vegetables.
Omega-⁠3 (EPA + DHA)They lower the liver's triglyceride output. The American Heart Association reports that 4 g/day of prescription omega-⁠3 lowers triglycerides by roughly 20 to 30%, with 1 to 2 g/day achieving about 5 to 10%. REDUCE-IT found 4 g/day of prescription EPA reduced cardiovascular events by 25% in statin-treated patients with elevated triglycerides.5Set with your prescriberWith the largest fat-containing mealPrescription omega-⁠3 is a medicine, not the same as a fish oil supplement. At high doses fish oil can have an antiplatelet effect, so tell your prescriber if you take a blood thinner. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day36, so check this dose with your clinician first.
Psyllium HuskA soluble fiber that binds bile acids in the gut, so the liver draws LDL from the blood to make more bile. Pooled trials show LDL falls by about 14 mg/dL (0.35 mmol/L).10Set with your prescriber30 minutes before meals with a large glass of waterStart at 5 g/day and increase over 2 weeks to prevent bloating and gas. Drink at least 8 oz (240 mL) of water per dose: psyllium without adequate water can cause GI obstruction. If on thyroid medication, take psyllium 4+ hours away (can interfere with absorption).
Aged Garlic Extract (AGE)Meta-analyses find a modest reduction in total cholesterol, about 9%, but reviewers call its robustness debatable and its value in treating high cholesterol questionable.7Set with your prescriberWith meals, can be split morning and eveningIf taking blood thinners, consult your physician: garlic has modest antiplatelet effects. Do not take with antiretroviral medications; it may reduce drug levels.
Artichoke Leaf ExtractIt is thought to reduce cholesterol production in the liver and increase bile acid excretion. A meta-analysis of 14 randomized trials found artichoke leaf extract lowered LDL by about 17 mg/dL18.Set with your prescriberAs your prescriber advisesIf you have gallstones, or have never been checked for them, agree on this with your clinician first: gallstones are common and usually silent, and stimulating gallbladder contraction when stones are present can trigger biliary colic or block a bile duct.
Vitamin K2 (MK-⁠7)Menaquinone-⁠7 activates Matrix Gla Protein, an inhibitor of arterial calcification. A three-year randomized trial reported improved arterial stiffness in healthy postmenopausal women. The evidence is small, and this is not established as a treatment for high cholesterol.8Set with your prescriberWith the largest fat-containing meal (fat-soluble)If you take a vitamin K antagonist blood thinner, K2 can affect your INR; consult your physician.
NattokinaseBleeding risk: do not take this without medical advice. A fibrin-degrading enzyme from fermented soy. A 26-⁠week randomized trial reported reductions in fibrinogen and clotting factors. Its safety trials excluded people taking anticoagulants, and case reports describe bleeding when it was combined with a prescription anticoagulant. Not appropriate alongside anticoagulant or antiplatelet medicines, including aspirin.11Do not start without medical advice, and never with a blood thinner or antiplatelet medicine.On an empty stomach or between mealsNever with blood thinners or antiplatelet medicines, including aspirin: significant bleeding risk. Discontinue 7 to 10 days before any surgery. Not suitable during pregnancy.
Niacin (Nicotinic Acid)No longer recommended for routine use. High-dose niacin does raise HDL and lower triglycerides and Lp(a), but two large outcome trials found those changes brought no benefit. AIM-HIGH was halted early for futility, and HPS2-⁠THRIVE, in 25,673 patients, found no reduction in major vascular events when niacin was added to statin therapy. Both found real harm: new-onset diabetes and worsened diabetic control, plus excess infections, bleeding and gastrointestinal, musculoskeletal and skin events. The National Lipid Association advises curtailing routine use in statin-treated patients. It retains a narrow role, decided by a specialist, in familial hypercholesterolemia, severe hypertriglyceridemia and statin intolerance.12Specialist decision only. Not a self-directed supplement.Set by the specialist, who also manages flushingIf a specialist prescribes niacin, liver enzymes (ALT, AST) are checked at baseline and periodically. It needs caution with active liver disease, gout or peptic ulcer; it is tapered rather than stopped abruptly and needs extra monitoring with a statin because of myopathy risk. Niacinamide is a different compound with no lipid effect and is not interchangeable.
CoQ10 (Ubiquinol)Essential for mitochondrial energy production and a lipid-phase antioxidant. Statins and red yeast rice both lower CoQ10 levels, which is why supplementing it is often suggested for statin-related muscle symptoms. Trial evidence for that is mixed and it is not established practice.9Set with your prescriberWith a fat-containing meal, for absorptionDiscuss it with your prescriber before taking it alongside red yeast rice or a statin. Choose a third-party tested product.

What to Expect Over Time

Diet and, where needed, medication lower LDL together; this is what trials and guidelines show about the pace for adults with high cholesterol.

Treatment and supportive care, together
First Weeks

LDL responds within weeks: in a closely supervised one-month trial of 46 adults, a diet built on the Portfolio foods lowered LDL by about 29%21. Pooled across 7 trials, the fall was smaller, about 17%2.

Months 1 to 3

A fasting lipid panel is repeated 4 to 12 weeks after starting a statin or changing its dose, to check the response to medication and lifestyle change13. Muscle aches are most likely in the first year on a statin, but in blinded trials over 90% of those reported were not caused by it, so raise them with your prescriber rather than stopping14.

Months 3 to 12

After that first check, lipids are rechecked every 3 to 12 months as needed13. After the first year of statin treatment, trials found no excess of new muscle symptoms14.

Long Term

The benefit grows with the size of the LDL fall: in 26 trials, each fall in LDL of about 39 mg/dL (1 mmol/L) cut major vascular events by just over a fifth a year, with no lower threshold found16.

When to Seek Care

Call 911 for chest pain that feels tight or squeezing or spreads to the arms, neck or jaw, or for severe breathlessness. Call too for a face drooping on one side, arm weakness or slurred speech, even if it passes, as this can be a stroke or mini-stroke22.

📬

Get new guides in your inbox. Once a month: new condition guides and research updates, including the trials that did not work. Free, no spam, and you can unsubscribe in one click.

Sign up

Lowering Cholesterol With Diet

Diet, with berberine, plant sterols and omega-⁠3 where they suit you, can lower LDL and triglycerides alongside medication where it is needed. In the best-studied dietary pattern of this type, LDL fell by about 17% across 7 controlled trials, and by 35% in one small 4-⁠week trial.2

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.9 This page is nutrition education, not medical advice, and it does not replace your doctor. If you take a statin or any lipid-lowering medication, do not change or stop it, and do not add a supplement, without speaking to your prescriber.

  1. Centers for Disease Control and Prevention. High Cholesterol Facts. cdc.gov. ↩
  2. Chiavaroli L, Nishi SK, Khan TA, et al. Portfolio Dietary Pattern and Cardiovascular Disease: a systematic review and meta-analysis of controlled trials. Prog Cardiovasc Dis. ScienceDirect. In 7 trial comparisons in 439 adults with high cholesterol, adding the Portfolio pattern to a cholesterol-lowering diet reduced LDL by about 17%, with high certainty evidence, PubMed 29807048. The 35% figure comes from a 4-⁠week trial in which 13 adults with high cholesterol ate the Portfolio diet and LDL fell by 35.0%, against 12.1% on a low saturated fat diet, PubMed 14624410. ↩ ↩ ↩ ↩
  3. Ju J, et al. Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials. PubMed 30466986. See also the sex-specific meta-analysis, PubMed 36941490. ↩ ↩ ↩
  4. European Food Safety Authority. Scientific opinion on the safety of monacolins in red yeast rice. PMC7009499. On product quality and citrinin contamination see PMC11202976, and Mayo Clinic's summary of red yeast rice. ↩
  5. Skulas-Ray AC, et al. Omega-⁠3 Fatty Acids for the Management of Hypertriglyceridemia: a Science Advisory from the American Heart Association. Circulation. 2019. ahajournals.org. ↩ ↩ ↩ ↩
  6. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. PMC10343346. Meta-analysis of 124 placebo-controlled trials in 9,600 adults. ↩ ↩ ↩
  7. Effect of garlic on serum lipids: an updated meta-analysis. PubMed 23590705. See also Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. NCBI Bookshelf. ↩ ↩ ↩
  8. Knapen MHJ, et al. Menaquinone-⁠7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thromb Haemost. 2015. ↩ ↩
  9. National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩
  10. Pooled analyses of psyllium and soluble fiber trials for LDL reduction, PubMed 38688104, a meta-analysis of randomized trials in adults reporting an LDL fall of about 0.35 mmol/L. It pooled 29 randomized trials in 2,769 adults. ↩
  11. Memorial Sloan Kettering Cancer Center, Nattokinase, mskcc.org. Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII and factor VIII in human subjects. Nutr Res. 2009, PubMed 19358933. The human trial evidence does not cover people taking anticoagulants, so the combination is unstudied rather than shown to be safe. ↩
  12. HPS2-⁠THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014;371:203-⁠212, and the AIM-HIGH Investigators, N Engl J Med. 2011;365:2255-⁠2267. National Lipid Association summary: lipid.org. ↩
  13. On when to recheck cholesterol: the ACC/AHA cholesterol guideline, as summarized for family physicians, advises repeating a fasting lipid measurement 4 to 12 weeks after starting a statin or changing its dose, to assess adherence and the response to medication and lifestyle changes, and every 3 to 12 months after that as needed. It sets the goal of moderate-intensity statin therapy as a 30 to 49% fall in LDL, and of high-intensity therapy as 50% or more, AAFP guideline summary, 2019. ↩
  14. On statins and muscle symptoms: an individual participant data meta-analysis of 19 double-blind placebo-controlled trials in 123,940 people found that statins caused a small excess of mostly mild muscle pain, mainly in the first year, and that more than 90% of the muscle symptoms reported by people taking a statin were not caused by it, PubMed 36049498. ↩
  15. On statins and diabetes: an individual participant data meta-analysis of large blinded statin trials found a 10% proportional increase in new diabetes diagnoses with low- or moderate-intensity statins and a 36% increase with high-intensity statins, with most new diagnoses in people whose blood sugar was already close to the diagnostic threshold, and noted that this is already counted within the overall reduction in cardiovascular risk, PubMed 38554713. ↩
  16. On how much statins reduce events: an individual participant meta-analysis of 26 randomized trials in about 170,000 people found that major vascular events fell in proportion to LDL lowering, rate ratio 0.78 per 1.0 mmol/L reduction, similar in all types of patient studied, so each 1.0 mmol/L reduction lowered the annual rate by just over a fifth, PubMed 21067804. ↩
  17. On curcumin and cholesterol: a meta-analysis of 64 randomized controlled trials found turmeric or curcumin lowered LDL by 4.89 mg/dL and total cholesterol by 3.99 mg/dL, with evidence assessed as low to very low certainty, PubMed 37230418. ↩
  18. On artichoke and cholesterol: a meta-analysis combining 15 effect sizes from 14 randomized trials found artichoke leaf extract lowered LDL by 17.48 mg/dL and total cholesterol by 17.01 mg/dL, with no significant effect on HDL, PubMed 34569671. ↩
  19. On how common high cholesterol is in the US: the CDC reports that about 86 million US adults have total cholesterol above 200 mg/dL, nearly 25 million above 240 mg/dL, and that slightly more than half of adults who could benefit from cholesterol medicine, 54.5%, are taking it, CDC, High Cholesterol Facts. ↩
  20. On what raises cholesterol: the CDC lists a diet high in saturated and trans fat, too little physical activity and weight gain, smoking, type 2 diabetes, age and inherited familial hypercholesterolemia as risk factors, CDC, High Cholesterol Risk Factors. ↩
  21. On how fast diet can work: in a 2003 randomized trial, 46 adults with high cholesterol ate a diet built on plant sterols, soy protein, viscous fiber and almonds for one month under close supervision, and LDL fell by 28.6%, not significantly different from a starting-dose statin in the same trial, against 8.0% on a low saturated fat control diet, PubMed 12876093. ↩
  22. On when to call for help: NHS guidance advises calling emergency services for chest pain that feels tight or squeezing, chest pain spreading to the arms, neck or jaw, or severe difficulty breathing, and for the stroke signs of face drooping, arm weakness and slurred speech, adding that someone whose symptoms disappear still needs assessment in the hospital, NHS, heart attack and NHS, TIA. ↩
  23. On cholesterol in food: an American Heart Association science advisory noted that recent guidelines dropped a specific dietary cholesterol target, found that observational studies in several countries generally show no significant link between dietary cholesterol and cardiovascular disease, and that most analyses of intervention trials link intakes above current averages with higher total or LDL cholesterol, and advised focusing on healthy eating patterns instead, PubMed 31838890. ↩
  24. On lipoprotein(a): the European Atherosclerosis Society's 2022 consensus statement reports that Lp(a) concentration is more than 90% determined by genetics, that lifestyle measures have minimal impact on it, and that high Lp(a) affects about 1.4 billion people worldwide and is a causal risk factor for cardiovascular disease and aortic valve stenosis. It recommends measuring Lp(a) at least once in adults, treats above 50 mg/dL (125 nmol/L) as raised risk, and does not recommend niacin for lowering it because two outcome trials showed no clinical benefit, PubMed 36036785. ↩
  25. On adding a cholesterol-absorption inhibitor to a statin: in the IMPROVE-IT trial of 18,144 people recently hospitalized with an acute coronary syndrome, average LDL was 53.7 mg/dL with the combination against 69.5 mg/dL on the statin alone, and major cardiovascular events at 7 years were 32.7% against 34.7%, PubMed 26039521. ↩
  26. On PCSK9 inhibitors: in the FOURIER trial of 27,564 people with cardiovascular disease already taking a statin, the injected PCSK9 inhibitor lowered LDL by 59% against placebo and reduced major cardiovascular events from 11.3% to 9.8% over a median 2.2 years, a hazard ratio of 0.85, PubMed 28304224. ↩
  27. On other lipid-lowering medicines: a clinical review reports that fibrates can lower triglycerides by as much as 50% and raise HDL by 5 to 20%, and that bile acid sequestrants bind bile acids in the gut to lower cholesterol, commonly cause gastrointestinal side effects such as bloating and cramping, can reduce the absorption of other medicines and call for monitoring of vitamin absorption in some patients, StatPearls, lipid-lowering drug therapy. ↩
  28. On nuts: a meta-analysis of 61 controlled trials in 2,582 people found that each daily serving of tree nuts lowered LDL by 4.8 mg/dL, with stronger effects at 60 g a day or more and no difference by nut type, PubMed 26561616. ↩
  29. On oats: a meta-analysis of randomized trials found that 3 g a day or more of oat beta-glucan lowered LDL by 0.25 mmol/L, about 10 mg/dL, without changing HDL or triglycerides, PubMed 25411276. ↩
  30. On green tea: a meta-analysis of 14 randomized trials in 1,136 people found green tea or its extracts lowered LDL by 2.19 mg/dL, PubMed 21715508. The European Food Safety Authority found that supplements giving 800 mg or more of EGCG a day raised liver enzymes in trials, and that rare liver injury has been reported even with the tea, PubMed 32625874. ↩
  31. On olive oil: in the PREDIMED trial of 7,447 adults at high cardiovascular risk in Spain, a Mediterranean diet supplemented with extra-virgin olive oil had a hazard ratio of 0.69 for major cardiovascular events against advice to reduce dietary fat, over a median 4.8 years, PubMed 29897866. ↩
  32. On avocado: a meta-analysis of trials found no significant change in LDL overall, but in people with high cholesterol avocado lowered LDL by 9.4 mg/dL, with the certainty of the findings graded low to very low, PubMed 36565850. ↩
  33. On beans, lentils and chickpeas: a meta-analysis of 26 randomized trials in 1,037 people found that about one serving a day, a median 130 g, lowered LDL by 0.17 mmol/L, about 7 mg/dL, PubMed 24710915. ↩
  34. On pectin and other soluble fibers: a meta-analysis of 67 controlled trials found that 2 to 10 g a day of soluble fiber lowered LDL by about 0.057 mmol/L per gram, that pectin, oat and psyllium fiber did not differ in effect, and that the effect is small within the practical range of intake, PubMed 9925120. ↩
  35. On stroke after a TIA: in a cohort of 1,707 people diagnosed with a TIA in 16 northern California emergency departments, 180 (10.5%) had a stroke within 90 days, 91 of them in the first 2 days, PubMed 11147987. ↩
  36. Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
  37. On trans fat in US foods: the FDA determined in 2015 that partially hydrogenated oils, then the major source of artificial trans fat, are no longer generally recognized as safe; manufacturers could not add them to most foods after June 18, 2018, with a final compliance date of January 1, 2021; trans fat also occurs naturally in milk, butter, cheese and meat, which the ruling did not affect, FDA, trans fat. ↩